Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Acad Emerg Med. 2011 Apr;18(4):374–384. doi: 10.1111/j.1553-2712.2011.01040.x

Table 1.

Diagnostic Test Characteristics of SBT, BAS, O3DY, and cAD8

Sensitivity, % (95% CI††) Specificity, % (95% CI) Positive Likelihood Ratio (95% CI) Negative Likelihood Ratio (95% CI) AUC^ (95% CI)
SBT 95 (88–98) 65 (61–67) 2.7 (2.2–3.0) 0.08 (0.03–0.2) 0.930 (0.862–0.971)
BAS 95 (88–98) 52 (48–54) 2.0 (1.7–2.2) 0.10 (0.03–0.3) 0.934 (0.867–0.974)
O3DY 95 (85–99) 51 (46–53) 2.0 (1.6–2.1) 0.10 (0.03–0.3) N/A
cAD8 83 (71–91) 63 (55–68) 2.2 (1.6–2.8) 0.27 (0.1–0.5) 0.816 (0.727–0.886)
SBT+cAD8* 91 (81–97) 27 (20–30) 1.2 (1.0–1.4) 0.32 (0.1–0.9) N/A
BAS+cAD8 97 (90–99) 11 (6–12) 1.1 (0.9–1.1) 0.27 (0.04–1.6) N/A
O3DY+cAD8 100 0 N/A N/A N/A
*

Abnormal SBT or abnormal cAD8.

Abnormal BAS or abnormal cAD8.

Abnormal O3DY or abnormal cAD8.

^

n = 102 subjects who had data for all four instruments collected.

††

Confidence intervals for the estimated parameters were computed based upon constant chi-square boundaries as described in Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: Wiley, 1981.

SBT = Short Blessed Test; BAS = Brief Alzheimer’s Screen; O3DY = Ottawa 3-Day-Year; AUC = area under the receiver operating characteristic curve; cAD8 = caregiver-completed Alzheimer’s Disease-8